A three-year, $15 million partnership between Cornell and NewYork-Presbyterian will employ artificial intelligence to help improve outcomes for people with cardiovascular disease.
Producing biomaterials that match the performance of cartilage and tendons has been an elusive goal for scientists, but a new material created at Cornell demonstrates a promising new approach to mimicking natural tissue.
There is considerable variation in the management of mantle cell lymphoma across different clinical settings according to an analysis by investigators.
Post-operative atrial fibrillation may be a marker for early-stage heart failure and may potentially contribute to its development, according to a new study.
Social justice and engineering blend beautifully. Last semester, Cornell students built a trailblazing food-sharing pantry to take an edge off chronic hunger among local residents.
A multidisciplinary team of Cornell researchers is collaborating to elevate the value of home care workers while improving their working conditions and patient outcomes.
Researchers analyzed the Omicron wave in Qatar last winter, comparing prior infections, vaccine immunity and combinations thereof among more than 100,000 Omicron-infected and non-infected individuals.
As the pandemic pomp and COVID circumstances dissipate, Cornell’s McGovern Center and Praxis Center incubators graduated five startups, putting them on the road to success.
A study suggests boosting “naturally-produced” antibodies in mothers may enhance infants’ immunity against bacterial pathogens that cause infectious gastrointestinal diseases.
